TORONTO, Ontario, Sept. 17, 2012 (GLOBE NEWSWIRE) -- Polydex Pharmaceuticals Limited (Pink Sheets:POLXF) (the “Company”) reports that its Order Book is currently full with contracts to produce $4 million of product through the next 8 months. With added new customers, and increased orders from a worldwide customer base, the production line is currently operating around the clock to meet the growing demand for the Company’s high quality dextran based products.
